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ABSTRACT
Purpose: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that displays a rapid evolution. Current treatments
have failed to revert clinical symptoms because the mechanisms involved in the death of motoneuron are still unknown. Recent
publications have put non-neuronal cells, particularly, astrocyte and microglia, in the scenario of pathophisiology of the disease. Animal
models for ALS, particularly transgenic mice expressing the human SOD1 gene with a G93A mutation (hSOD1), are available and
display the phenotype of the disease at cellular and clinical levels. However, it is a lack of detailed information regarding the methods to
study the disease in vitro to better understand the contribution of non-neuronal cells in the onset and progression of the pathology.
Methods: Colonies of Swiss mice and transgenic mice expressing hSOD1 mutation as well as non-transgenic controls (wild-type) were
amplified after a genotyping evaluation. Disease progression was followed behaviorally and mortality was registered. Highly purified
primary cultures of astrocytes and microglia from mouse spinal cord were obtained. Cells were identified by means of GFAP and CD11B
immunocytochemistry. The purity of astroglial and microglial cell cultures was also accompanied by means of Western blot and RT-PCR
analyses employing a number of markers. Results: The disease onset was about 105 days and the majority of transgenic mice displayed
the disease symptoms by 125 days of age and reached the endpoint 20 days later.  A substantial motor weakens was registered in the
transgenic mice compared to wild-type at the end point. Immunocytochemical, biochemical and RT-PCR analyses demonstrated a highly
purified primary cultures of spinal cord astrocytes and microglia. Conclusion: It is possible to achieve highly purified primary cultures
of spinal cord astrocytes and microglia to be employed in cellular and molecular analyses of the influence of such non-neuronal cells in
the pathophysiology of ALS.
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RESUMO
Objetivo: A esclerose lateral amiotrófica (ELA) é uma doença neurodegenerativa fatal com evolução rápida. Os tratamentos atualmente
disponíveis falham em reverter os sintomas porque os mecanismos envolvidos na morte do neurônio motor ainda não são conhecidos.
Publicações recentes colocam as células não neuronais, particularmente o astrócito e a microglia, no cenário da fisiopatologia da doença.
Modelos animais para a ELA, particularmente os camundongos transgênicos que expressam o gene da SOD1 humana (hSOD1) mutante
estão disponíveis e mostram o fenótipo da doença ao nível celular e clínico. Entretanto, informações detalhadas são escassas sobre os
métodos de estudo da doença in vitro para a melhor compreensão da participação das células não neuronais no início e na progressão da
patologia. Métodos: Colônias de camundongos Swiss e camundongos transgênicos que expressam a hSOD1 mutante assim como os
controles não transgênicos (selvagem) foram amplificadas após avaliação genotípica. A progressão da doença foi acompanhada pelo
comportamento e a mortalidade foi registrada. Culturas primárias altamente purificadas de astrócitos e microglia da medula espinal dos
camundongos foram obtidas. As células foram identificadas pela immunocitoquímica da GFAP e CD11B. A pureza das culturas de
astrócitos e microglia foi acompanhada pelas análises do Western blot e RT-PCR empregando-se marcadores específicos. Resultados:
Os primeiros sinais da doença ocorreram por volta dos 105 dias de vida e a maioria dos camundongos transgênicos já estava com a
doença manifestada aos 125 dias de idade e alcançaram o estágio terminal aproximadamente 20 dias depois. Fraqueza substancial da
força muscular foi registrada nos animais transgênicos comparados com os animais selvagens. Análises imuncitoquímica, bioquímica e
pelo RT-PCR demonstraram culturas primárias altamente purificadas de astrócito e microglia da medula espinal dos camundongos.
Conclusão: É possível obter culturas purificadas de astrócitos e microglia da medula espinal do camundongo a ser empregadas em
análises celulares e moleculares da influência destas células não neuronais na fisiopatologia da ELA.
Descritores: Esclerose Amiotrófica Lateral. Astrócitos. Microglia. Neurônios. Técnicas de Cultura de Células. PCR. Camundongos Transgênicos.
1Research performed at Neuroregeneration Center (LIM 45), Department of Neurology, School of Medicine, University of São Paulo (USP), Brazil.
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Introduction
Amyotrophic lateral sclerosis (ALS) is a human devastating
and progressive neurodegenerative disorder that result in the
selective death of motoneurons in the central nervous system.
This progressive motoneuron degeneration culminates in muscle
wasting and patient death on average three to five years after onset
of the disease from respiratory failure1.
The main neuronal cells undertaking degeneration are the
upper giant motoneurons of layer V of the motor cortex and their
projecting lower motoneurons that are located in the motor nuclei
of the brainstem and in the anterior horn of the spinal cord. The
degeneration of the lower motoneurons that project to skeletal
muscles is responsible for the majority of the neurological
impairments of ALS patients. Affected motoneurons often contain
characteristic inclusions in their perikarya, dendrites and axons
however, more recently in the era of molecular biology, new
mechanisms of ALS have been elucidated and the involvement of
non-neuronal cells have been described2.
The knowledge on etiology and pathogenesis of ALS
motoneuron death has been gained on the inherent limitation of
human tissue from patients at the terminal stages, which makes it
difficult to interpret events in the intermediate phases of the
disease progression. Therefore, the search for animal models of
ALS to gain insights into both the mechanisms of motoneuron
death and therapeutic targets has allowed new information on the
pathogenesis of ALS3. In fact, animal models have provided
substantial advance into mechanisms that lead to motoneuron
degeneration4.
The majority of ALS cases are apparently sporadic,
with 90-95% of patients presenting disease symptoms without a
familial history of the pathology, being the remaining 5-10%
patients included as a familial ALS group, and about 25% of
familial cases are caused by dominant mutations in the Cu/Zn
super oxide dismutase (SOD1) gene5.
Identification of pathogenic alleles of SOD1 has led to
the generation of transgenic mouse and rat, models for ALS
studies. Overproduction of mutant human SOD1 protein in these
models leads to a late-onset and a progressive motoneuron
neurodegenerative disease. Such models have provided the
identification of intrinsic pathogenic characteristics of ALS
motoneurons, including the formation of protein aggregates,
cytoskeletal abnormalities, proteosome dysfunction and increased
sensitivity to cell death signals as well as the glial reactivity in the
disease evolution6.
SOD1 mutant enzyme retains full enzymatic activity.
Furthermore, experiments conducted in transgenic mice and rats
bearing ALS-associated human SOD1 (hSOD1) mutations as well
as SOD1 knockout mice indicate that SOD1-mediated toxicity is
not due to a loss of function but rather to a toxic gain of function
of the mutant protein. Taking together, results from in vivo and
in vitro studies suggested that disease onset/progression is
independent of the intrinsic SOD1 activity.
From the hitherto identified 119 mutations in the
human SOD1 gene, more than 10 transgenic mouse lines have
been established, and three of them (SOD1G93A, SOD1G85R, and
SOD1G37R) have been used extensively to study ALS pathology
experimentaly7.
Disturbed neuron–glia signaling leads to an impaired
synaptic transmission and neurotrophic support, triggering
neuronal cell death in a number of circumstances for instance
ALS, prion diseases, Parkinson’s disease, Alzheimer’s disease, etc.
Studies on transgenic mouse in vivo and in vitro have been
conducted to investigate whether neuron-specific expression of
mutant SOD1 (mSOD1) protein is sufficient to produce an ALS
phenotype or whether it might depend on the presence of mutant
protein in glial cells8,9.
In fact, evidence has been obtained that accumulation of
mSOD1 in postnatal motoneurons is not sufficient to induce or
accelerate neuronal death in ALS mice. Recent experiments have
shown that the presence of non-neuronal cells, harboring SOD1
protein, in proximity to motoneurons appears to be a prerequisite
for selective neuronal death, at least in later stages of the disease.
However, the underlying molecular mechanisms that lead to the
impairment of neuron–glia signaling in the ALS have only been
partially demonstrated10.
In view of the above descriptions, methods to study glial
influence on motoneuron death in ALS should be optimized. We
presented in this paper our experience in obtaining non-neuronal
cells to study ALS at cellular and molecular levels in vitro.
Methods
Swiss mice and also transgenic mice expressing the
human SOD1 (hSOD1) gene with a G93A mutation11 were
purchase from the Jackson Laboratory (Bar Harbor, ME, USA) and
maintained as hemizygotes by mating transgenic males with
B6SJLF1/J females. Non-transgenic littermates were used as controls
(wild-type). The colony was derived at Jackson Laboratories from
G93A mutant mice with 25 ± 1.5 copies of the human SOD1
transgene12. The mice identification (mutant or wild-type) in our
colony was performed by a genotyping method.
The animals were maintained in specific pathogen-free
environment, in the biotery of the University of São Paulo. The
mice were kept under controlled temperature and humidity
conditions with a standardized light-dark cycle (lights on at
7.00 a.m. and off at 7.00 p.m.) and free access to food pellets and
tap water. The study was conducted under protocols approved
by the Animal Care and Use Ethic Committee at University of
São Paulo and in accordance with the Guide for the Care and Use
of Laboratory Animals.
Genotyping
The DNA was extracted from mice tails by using the
following protocol: 500µl of K proteinase buffer 1mg/ml (Sigma
Chemicals, EUA) (TrisHCl 20mM pH 8.0, NaCl 10mM, EDTA
30mM pH8.0 e SDS 0.5%) were added to each sample of tail. The
suspension was incubated at 55 to 60°C during 48 hours and then
centrifuged (16,000g/10 minutes, at 4°C). The aqueous phase was
replaced into a new tube and 500µl cold isopropanol were added.
After gently mixing, DNA became visible and could be precipitated
for centrifugation (16,000g/2 minutes, at room temperature). The
DNA pellet was washed twice with 500µl ethanol 70%. After
removal of ethanol and 5 minutes drying, the DNA was resolved in
50µl TE buffer (10 mM Tris-HCl pH 7.4; 1mM EDTA in deionized
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water). DNA samples were stored at 4°C until PCR assay. PCR
assay was performed as described earlier by Rosen et al.2, by using the
following primers: IMR113 (5’-ATCAGCCCTAATCCATCTGA-3’) and
IMR114 (5’-CGCGACTAACAATCAAAGTGA-3’) to amplify SOD1h
fragment IMR042 (5’-CTAGGCCACAGAA TTGAAAGATCT-3’)
and IMR043 (5’-GTAGGTGGAAATTCTAGCATCATCC-3’) to
amplify a fragment of murin interleucin-2 as positive control. For
each sample, PCR assay included 12.5µl PCR Master Mix (2X)
(Fermentas Life Sciences), 0.5µl of each primer described above,
1µg DNA and water free from nucleotides for a final volume of
25µl, submitted to an initial period of 3 minutes at 95ºC, followed
by 36 PCR amplification cycles (30 seconds at 95ºC, 30 seconds
at 60ºC and 45 seconds at 72ºC) and finally 2 minutes at 72°C.
PCR products with 1µl blue green could be visualized in an 1%
agarosis gel.
Behavior analysis by means of hanging wire test
Neuromuscular strength was tested by the hanging wire
test13. Each mouse was placed on the wire lid of a conventional
housing cage. The lid was gently turned upside down, 30 cm above
a soft surface to avoid injuries. The latency to fall was timed. Each
mouse was given up to three attempts to hold on the inverted lid
for a maximum of 180 seconds and the longest period was recorded.
Primary cultures of spinal cord cells
Astrocyte culture
The protocol used for primary spinal cord astrocyte
cultures is a combination of previously protocols published8 and
modification according to our experience. Post-natal day 0 (within
24 hours of birth) mouse pups were decapitated. The skin and
muscles overlying the spinal cord were dissected. Spinal cord
between mid-cervical and lower lumbar levels was cut and quickly
cleaned of meninges in ice-cold Hank’s modified balanced salt
solution (HBSS; LCG Biotechnology), and the spinal cord tissue
from 10 animals was pooled in fresh ice cold HBSS. The tissue
was triturated with a Pasteur pipette and subsequently passed
through 19G needle in Dulbecco’s modified eagle medium (DMEM;
Cultilab) containing 10% fetal bovine serum (FBS; Gibco), and
100U/ml penicillin and 100U/ml streptomycin (Sigma). The cell
suspension was pelleted at 900 r.p.m. for 5 minutes, the
supernatant was removed and the pellet resuspended in fresh
DMEM at 1ml per dissected cord segment. The resuspended cells
were plated onto 6-well culture plates, and maintained at 37°C in a
5% CO2/95% air atmosphere. The cultures were fed every second
day with fresh DMEM. After 2 weeks, the cells were agitated
(200 r.p.m. for 6 hours) to eliminate residual microglia and
oligodendrocytes, then astrocytes were detached by 0.25% trypsin
(Gibco) and plated onto coverslips.
Microglial culture
Mouse mixed glial cultures were prepared as previously
described14 and adapted by our group. Spinal cords from 1 or
2-day-old neonatal mice were dissected, carefully stripped of
their meninges and digested with 0.25% trypsin (Gibco) for 30
minutes at 37ºC. Trypsinization was stopped by adding an equal
volume of culture medium (DMEM F12 nutrient mixture, FBS
10%, penicillin 100U/ml and streptomycin 100µg/ml) to which
0.02% deoxyribonuclease I (Sigma) was added. The solution was
pelleted, re-suspended in culture medium and brought to a single
cell suspension by repeated pipetting followed by passage through
a 19G needle. Cells were seeded at a density of 250,000 cells/ml
(¼ 62,500 cells/cm2) and cultured at 37ºC in humidified 5%
CO2-95% air. Medium was replaced every 4-5 days. Cultures
reached confluency after 7-10 days in vitro. After, mixed glial
cultures have been confluent for at least 3 days. Mixed glial cells
have been washed for 1 minute in DMEM F12 to eliminate serum.
After this, the cells were incubated at 37ºC with 500µl per well of
trypsin 0.25%: DMEM F12 1:3 until intact layer is detached. This
step takes 4 hours. Next, 500µl of DMEM F12 with 10% fetal
bovine serum was added for trypsin inactivation and the medium
containing the layer of detached cells was aspirated and replaced
for biochemical analysis. Microglial adherent cells could be grown15,
and incubated with trypsin 0.25% and replated onto coverslips for
imunohistochemical and biochemical analysis.
Immunocytochemistry
One-color immunohistochemistry
Cell cultures were rinsed 2 times with phosphate buffered
saline (PBS), and then fixed in paraformaldeyde (30 minutes, at
4ºC). Sequential incubation of the fixed cells then took place at
room temperature in: (1) wash in PBS for 5 minutes in agitation;
(2) wash in PBS with 1% Triton for 10 minutes; (3) wash in PBS
with 0.02% Tween 20 (BioRad) for 5 minutes; (4) wash in PBS
with 0.02% Tween 20 and 1% BSA (Sigma) for 5 minutes; (5)
block in PBS with 2% normal goat serum (NGS), 4% BSA, 0.2%
Triton (Sigma) for 30 minutes; (6) primary antibody incubation:
using rabbit polyclonal glial fibrillary acidic protein (GFAP), a
protein of the intermediate filament of the astroglial cytoskeleton
(Dako) at 1:150 dilution for astrocytes cultures, CD11B (marker
for microglia, BD Biosciences) at 1:600 dilution for microglial
cultures in 2% NGS, 4% BSA, 0.2% Triton in PBS overnight.
(7) wash 3 times with PBS; (8) secondary antibody incubation
with biotinylated anti-rabbit IgG (Vector Laboratories) at 1:250
dilution in PBS with 0.2% Triton, 1% NGS, 2% BSA for 2 hours
except for microglial cultures that were incubated with a primary
biotinylated antibody; (9) wash 3 times with cold PBS; (10)
Incubation with avidin-biotin at 1:125 dilution in PBS; (11) wash
again 3 times with PBS; (12) DAB reaction until color observation.
The reaction was made in 0.01% H2O2, 0.5mg DAB/ml. DAB
labeled cultures were washed 3 times with distillated water, and
the reaction was interrupted with Trizma.
Two-color immunohistochemistry
Furthermore, two-color immunoperoxidase was used
for further evaluation of the simultaneous detection of the
GFAP (marker for astrocytes) and CD11B (marker for microglia)
immunoreactivities in the astroglial cultures.
As t rogl ia l  cu l tures  were  submi t ted  to  GFAP
immunocytochemistry as described above employing the DAB
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as a chomogen, which gave a brownish color to the immunoreactive
product. Following the DAB reaction, the plated cells were rinsed
several times in PBS and incubated over 24 hours at 4°C with the
CD11B antiserum described above diluted 1:600. After incubated
with the avidin-biotin solution (both diluted 1:250, Vectastain,
Vector) for 45 minutes at room temperature, and stained for 10
minutes using 0.05% 4-chloro-naphthol (Sigma) as a chromogen
and 0.05% (v/v) H2O2 (Sigma). The plated cells were rinsed in
PBS and cover-slipped in a glycerol phosphate buffered medium.
The sections were analyzed and photographed with an AX70
Olympus photomicroscope (U.S.A).
Western blot analysis of cultured cells
GFAP, IBA1 and chondroitin sulfate proteoglycan (NG2)
protein levels were assessed by Western blot analysis. The astroglial
and microglial cell cultures were homogenized in lysis buffer
containing 1% protease inhibitor cocktail (Sigma), 1% NP40 (Sigma),
0.5% sodium deoxycholate (Sigma), 1% sodium dodecyl sulfate
(Sigma), 1mM ethylenediaminetetraacetic acid (Sigma), 1mM
ethylene glycol tetraacetic acid (Sigma), diluted in phosphate
buffered saline (PBS, pH 7.4) and then homogenized. The
homogenate was centrifuged (14,000r.p.m.) for 20 minutes at 4ºC;
supernatants were transferred into new tubes and stored at -70ºC
until use. After centrifugation at 14,000 r.p.m. for 20 minutes, the
supernatants were transferred into new tubes and stored at -70ºC
until use. Protein concentrations were determined according to
the method described by Bradford16.
To label a GFAP and NG2 bands, the samples were
separated on a sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (20µg of protein/lane) using a 12% Tris–HCl ready
gel (Bio-Rad, California, USA) at 100V for 1 hour. For to NG2, the
samples were separated on a sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (80µg of protein/lane) using a 6% Tris–HCl
ready gel (Bio-Rad, California, USA) at 100V for 1 hour. Proteins
were transferred to nitrocellulose membrane for 1 hour at 100V.
After 1hour blocking with 5% milk in Tris-buffered saline 0.05%
Tween 20 (TBS-T). Membrane was incubated overnight with rab-
bit polyclonal antibodies to GFAP (1:10,000, DAKO) and to NG2
(1:500, Chemicon), the antisera were diluted in 3% milk/TBS-T.
Membrane was washed 2 times for 10 minutes in TBS-T and
incubated at room temperature for 1 hour with anti-rabbit a 1:10,000
dilution of anti-rabbit IgG–ECL conjugated secondary antibody
(Santa Cruz Biotechnology, USA).
For to IBA1 band, the samples were separated on a
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(80µg of protein/lane) using a 15% Tris–HCl ready gel (Bio-Rad,
California, USA) at 130V for 40 minutes. Proteins were transferred
to PVDF membrane for 40 minutes at 50V. After 24 hours blocking
with 5% BSA in Tris-buffered saline 0.05% Tween 20 (PBS-T).
Membrane was incubated for 1 hour with rabbit polyclonal
antibodies to IBA1 (1:2,000, WAKO), the antisera were diluted in
PBS-T. Membrane was washed 2 times for 10 minutes in PBS-T
and incubated at room temperature for 1 hour with anti-rabbit a
1:10,000 dilution of anti-rabbit IgG–ECL conjugated secondary
antibody (Santa Cruz Biotechnology, USA).The IBA1 protein is a
17kDa protein consisting of 147 amino acids. The genomic copy of
the IBA1 gene was mapped to within the major histocompatibility
complex MHC class III region between the BAT2 and TNF-Į 
genes. Using a specific antibody, IBA1 protein was shown to
be expressed in monocytic cell lines and microglia among the
cultured brain cells. IBA1 protein functions as an adapter molecule
that mediates calcium signals in the monocytic lineage, including
microglia.
Blots were washed two times with TBS-T and once TBS.
After final washes, the membrane was incubated with Western
Lightning Chemiluminescence Reagent Plus (PerkinElmer Life
Science, USA) for 1 minute. The membranes were exposed to an
X-ray film for imaging (HyperfilmTM ECL, Amersham Biosciences,
USA) to visualize protein bands.
Gene expression by means of RT-PCR
RT-PCR was performed with oligonucleotide primes
5 ’ - G C A G A G AT G AT G G A G C T C A AT G A C C - 3 ’ a n d
3 ’ - G T T T C AT C C T G G A G C T T C T G C C T C A - 5 ’ .  Total
RNA was extracted by Trizol method. Firstly, 1ml Trizol solution
was added to the cell sample, and then 200µl chloroform were
added. After mixing, the phases were separated by centrifugation
(12,000g/15 minutes at 4°C). The aqueous phase was transferred
to a new tube and 500µl isopropanol was added. After mixing
and incubation for 10 minutes at room temperature, RNA was
precipitated by centrifugation (13,000g/10 minutes at 4°C).
The precipitate was washed with 75% ethanol and centrifuged
(1,500g/5 minutes at 4°C). After removal of the ethanol and 15
minutes drying, the RNA was resolved in 50µl RNAse free water.
Complementary DNA (cDNA) templates were prepared from 1µl
of total RNA with 2µl RNAse free water and Kit Ready-to-go
RT-PCR beads (GE healthcare), according to the manufacturer’s
recommendations, followed by 40 PCR amplification cycles (94°C
for 30 seconds, annealing at 60°C for 60 seconds and extension at
72°C for 90 seconds). Ten µl of PCR product was analyzed by 2%
agarose gel with 2µl of ethidium bromide.
Data analysis
The Student t-test was performed to compare data from
behavior analysis of the different groups of animals. Data were
presented as mean ± S.E.M. and significance level was set at p<0.05.
Results
Genotyping
The animals were identified as mutant or wild-type by
genotyping. These assignments were successfully performed
in all mice DNA samples, and were validated by agarose gel
electrophoresis of PCR products. The genotype result was
determined by analysis of the bands observed. Detection of
two bands was clearly observed in mutant mice B6SJL-
TgN(SOD1-G93A)1 Gur with 236 pb and 324 pb. Wild-type mice
showed one band with 324 pb (Figure 1).
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FIGURE 1 – Procedure of genotyping in order to
determine the fenotype, mutant and wild-type to the
enzime human superoxid dismutasis 1 (SOD1).In the
mutant mice B6SJL-TgN(SOD1-G93A)1 Gur
(SOD1) two bands can be observed, the mutant
one (236 pb) and the wild-type one (324 pb).
Otherwise, in the wild-type mice, only 324 pb band
can be seen. Interestingly, 324 pb band have a
stronger marking in wild-type mice than in SOD1
animals, as expected because of the higher number
of copy of mutant enzyme in transgenic mice
comparing to the wild-type form of the enzyme
FIGURE 2 – The figure illustrates the differences
in survival between mutant (SOD1) and wild-type
animals (A) and the hanging wire test for muscle
strength. The hanging wire test was expressed in
terms of mean latency for each group. Data are means
± SEM. *p<0.001 (Student t test) (B)
Marker
324pb
236pb
SOD1 SOD1 SOD1 WT SOD1 WT
General aspects and behavior
Animals were examined daily in their cages by a trained
observer. Around the age of the 105 days, the first clinical signs
of an abnormal and slow gait appeared in mutant animals.
Additionally, mice showed slight trembling of the hind limb when
they were suspended by their tails during normal cage maintenance.
These signs were observed in both females and males mice whereas
wild-type littermate controls never displayed those motor
symptoms. The majority of transgenic mice was such around 125
days of age and reached the endpoint 20 days later. At death,
mutant animals showed a complete paralysis.
Disease onset is when these signs appear and will extend
to symmetrical paralysis of the hindlimbs, followed by a complete
paralysis at the end stage. Mice were killed when they were unable
to roll over within 20 seconds after being pushed on their side, and
this time point was recorded as the time of death. Survival of our
transgenic mice is illustrated in Figure 2A.
The performance on hanging wire test showed more
evidenced differences between transgenic and wild-type animals
(around 120 days). During the entire period of analysis all control
animals continued to perform at the maximum level (Figure 2B).
Immunocytochemistry
A high number of putative cultured astroglial cells was
confluent and occupied the majority of the spaces in the plate
surface as seen under phase contrast microscopy (Figure 3a).
Immunocytochemistry demonstrated the presence of a strong
labeling of GFAP in the cytoplasm and processes of the cultured
astroglial cells (Figure 3b). All astrocytes in the culture stained for
GFAP immunoreactivity. Confluent astrocytes possessed a round
to elliptic shape with 2 long well visible processes (Figure 3b).
Moreover, the cultures of astroglial cells stained for CD11B
immunoreactivity demonstrated the presence of only very few
and scattered microglia in the astroglial cultures (less that 1%)
(Figure 3c).
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FIGURE 3 – Digital microphotographs of
confluent cultured purified astrocytes from
mouse spinal cord under phase contrast (a) and
immunolabelled for GFAP (b) or CD11B (c).
Immunoperoxidase technique was applied
with DAB as a chomogen. GFAP and CD11B
were markers for astrocytes and microglia,
respectively. The majority of cultured cells
were astrocytes labeled for GFAP (B) and only
the minority of the cells were microglia labeled
for CD11B (c). Bars: 20µm (a) and 30µm (b,c)
FIGURE 4 – Digital microphotographs of confluent cultured purified
microglia from mouse spinal cord [Swiss mice (a-c) and transgenic mice
expressing the human SOD1 (hSOD1) gene with a G93A mutation (d)]
under phase contrast (a,b,d) and immunolabelled for CD11B (c,d).
Immunoperoxidase technique was applied with DAB as a chomogen.
CD11B was a marker for microglia. The majority of cultured cells were
microglia labeled for CD11B (c). Bars: 20µm (a), 10µm (b), 50µm (c)
and 5µm (d)
The analysis of microglial cultures of the spinal cord mice
demonstrated a high number of putative cultured microglial cells
that were confluent and occupied the majority of the spaces in the
plate surface as seen under phase contrast microscopy (Figure 4a).
Already under phase contrast, it was possible to see a number of
highly ramified microglial processes of second and third order
surrounding each cell (Figure 4b,d). Immunocytochemistry
demonstrated the presence of a strong labeling of CD11B in
the membrane of the cell cytoplasm and process of the cultured
microglial cells (Figure 4c). All microglial cells in the culture stained
for CD11B. Confluent microglia with their processes possessed a
round to elliptic shape (Figure 4c,d). Moreover, the cultured
microglial cells stained for GFAP immunoreactivity showed no
immunoreaction (data not shown).
Western blot analysis
Western blot technique revealed that GFAP protein, an
astroglial protein, level is more intense in the purified astroglial
culture than purified microglial culture (Figure 5). No GFAP band
was detected in the supernatant cells derived from the purification
process of microglial cell cultures. Furthermore, the IBA1 protein,
a microglial protein, level is more intense in the purified microglial
culture than purified astrocyte culture. However, the western blot
revealed the band of the NG2 protein, a glycoprotein present in
oligodendrocyte/astrocyte precursors, only in astrocytes cultures,
that have been either or not purified (Figure 5).
FIGURE 5 - The bands of GFAP (upper panel), IBA1 (middle panel)
and NG2 (lower panel) proteins detected in pimary cultured cells from
mouse spinal cord by means of Western blot technique. The GFAP,
IBA1 and NG2 bands were about 50 kDA, 17 kDA and 270 kDA,
respectively. Figure illustrate the bands of GFAP (protein of the
intermediate filament of the astroglial cytoskeleton), IBA1 (a calcium
modulator that is shown to be expressed in microglia) and NG2
(a glycoprotein detected in oligodendrocyte/astrocyte precursors)
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Two-color immunoperoxidase for simultaneous
visualization of astrocytes and microglia in culture plates
Two-color immunoperoxidase method for simultaneous
detection of GFAP and CD11B immunoreactivities in primary
cultured astrocytes from mouse spinal cord demonstrated the
presence of a large number of brownish color (DAB as a
chromogen) immunoreactive astrocytes and scattered bluish
color immunoreactive microglia (4-chloro-naphthol as achromogen)
in the plate (Figure 6).
Discussion
We have introduced the colony of transgenic mice model
of ALS and the control animals for the disease in the biotery of
the University of São Paulo Medical School. The animals were
obtained from a specialized company abroad in producing
genetically modified strains for experimental studies. We have
followed the recommendations of the sender regarding
amplification of the colonies of transgenic mice expressing the
human SOD1 (hSOD1) gene with a G93A mutation11. The animals
were maintained as hemizygotes by mating transgenic males
with B6SJLF1/J females. The transgenic littermates possessed a
number of copy of the human SOD1 transgene that is adequate to
trigger disease onset by post natal day 105 as observed in our
colonies in agreement to descriptions of groups that have used the
same type of animals bearing the mutation4. Genotyping was used
to detect or exclude the mutations in the littermates. Non-transgenic
littermates that were called wild-type mice were used as controls.
We have also used Swiss mice to compare the results regarding
colony amplification, mortality and behavioral impairments as well
as results obtained in the bench.
The animals were maintained in a specific pathogen-free
environment in our biotery, being submitted to periodical
bacteriological and proctoparasitological survey which may
favor the colony amplification and homogeneity of results.
The mortality rate and longevity of G93A transgenic
mice were in agreement to that described in the literature with a
complete disease accomplishment onset around post natal day 125
FIGURE 6 – Primary astroglial culture obtained
from mouse spinal cord submitted to a two-color
immunoperoxidase procedures for simultaneous
detection of GFAP (marker for astrocytes) and
CD11B (marker for microglia) immunoreactivities.
GFAP immunoreactivity is identified as a brownish
color (diaminobenzidine as a chromogen) and
CD11B immunoreactivity as a bluish color (4-chloro
naphthol as a chromogen). Arrows indicate the
presence of a large number of immunopositive
astroglial cells and the double arrow illustrates the
presence of a scattered  immunoreactive microglia.
Bars: 50µm
Control cultures incubated with the solvent for the
primary antibodies, secondary antibody, or for avidin-biotin
showed no reaction (data not shown).
Gene expression
The RNA of astrocyte culture cells was isolated and
then transformed in cDNA by reverse transcriptase and amplified
using GFAP primers. The cDNA was detected by agarose gel
electrophoresis of PCR products. The reverse-transcriptase-PCR
result showed a GFAP specific band of 260 pb (Figure 7).
FIGURE 7 - Agarosis gel showing RNA
expression of glial fibrillary acid protein
(GFAP) in an astrocyte cell culture from
mouse spinal cord.  Sample was obtained
by RT-PCR performed with oligonucleotide
primers to GFAP (sense primer:
GCAGAGATGATGGAGCTCAATGACC
and antisense p r i m e r :
GTTTCATCCTGGAGCTTCTGCCTCA).
The detection of a 260 pairs of basis band
confirms astrocyte presence in the culture
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and endpoint by 145 days of age. The average of 20-40 days
of disease evolution and termination already confirms the fast
progression of neurological impairments which culminate to
respiratory failure and death11.
There are several tests in the literature that have been used
to follow voluntary motor deterioration in animal model of ALS
i.e. rotarod test, hanging wire test and electromyography. In the
present paper we have employed the hanging wire test that
seems to be very sensitive to demonstrate disease onset. From the
behavioral results demonstrated herein, we can confirm that
genotyping can predict disease onset at early adult life in hundred
percent of animals in accordance to the literature13.
We have also revised in this paper the method to obtain
primary culture of astrocytes8 and microglia15 which have been
adapted and optimized by our group for neuroglial cells from
spinal cord of mice for in vitro cellular, biochemical and molecular
analyses.
Based on the methodological descriptions presented in
this paper, we obtained primary cultures of mouse spinal cord
astrocytes with more than ninety-five percent purity which is
considered a good index for in vitro studies8,15. The phase contrast
microscopy of the live cultured astrocytes showed cells with
adequate vitality and morphological shape, resembling plated
astrocytes .  Cytological  phenotype was confirmed by
immunocytochemical labeling for GFAP, the intermediate filament
of astroglial cytoskeleton, after paraformaldehyde fixation of
astroglial primary cultures. Furthermore, the CD11B
immunolabeling of fixed astroglial cultures revealed the presence
of very few and scattered immunopositive microglia in the plate,
thus confirming that the method leads acquisition of a remarkably
purified astroglial culture.
As observed for astroglial cultures, we acquired primary
cultures of mouse spinal cord microglia with more than ninety-five
percent purity which is considered an excellent index for in vitro
studies with that type of cell8. Phase contrast microscopy showed
healthy live cultured microglia possessing morphological shape
of so described plated cells15. The qualitative analysis based on
cytological phenotype was confirmed by immunocytochemical
labeling for CD11B, a cell surface receptor complement described
with the method in the fixed cells. Furthermore, the GFAP
immunolabeling of fixed microglial cultures revealed the presence
of very few and scattered immunopositive astrocytes in the
plate, thus prompting the acquisition and expansion of a purified
microglial culture.
We have also demonstrated by means of Western blot
technique that the obtained primary neuroglial cultures allow
biochemical evaluation of protein contents in the plated cells after
ressupension, homogenization and protein extraction which is
very useful in the quantitative studies of molecular signaling
that participates in the pathophysiological mechanisms of the ALS
disease17. We have employed the Western blot analysis to further
characterize the identity and purity of astroglial and microglial
cultures. Purified microglial cultures showed a strong 17 kDA band
of IBA1 immunoblot and almost no detectable 50 kDA GFAP band.
In the other way, purified astroglial cultures showed an intense
GFAP band and a slight IBA1 band, indicating a well acceptable
degree of purity of both cell types by means of a biochemical
method. The method was also employed to detect NG2, a marker
of oligodendrocyte/protoplasmic astrocyte precursors, in both
non-purified and purified astrocytes, but not in microglial culture,
an indication that those precursor cells are displaying mitogenic
activity in culture. Moreover, it is of substantial interest the
observation of the absence of GFAP, IBA1 and NG2 in the seeded
supernatant cells after confluence from the process of microglial
culture purification. That finding does emphasize the necessity of
a good method to acquire cell culture purification18, because other
type of cells, probably endothelial, ependimal and meningeal
fibroblast cells, are present in the initial phases of the process and
showed be eliminated. As far as we know, this is the first time the
degree of purity has been detailed in the described methods to
obtain those primary cultured non-neuronal cells derived from
mouse spinal cord.
We have also demonstrated in this paper the RNA
expression of GFAP in purified mouse astrocyte cultures by
means of RT-PCR technique. Besides the importance of the
method to characterize the plated cells, RT-PCR can be employed
for molecular analysis of contribution of non-neuronal cells in
the pathophysiological mechanisms of ALS progression.
Conclusion
It is possible to achieve highly purified primary cultures
of spinal cord astrocytes and microglia to be employed in cellular
and molecular analyses of the influence of such non-neuronal cells
in the pathophysiology of ALS.
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